These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32104351)

  • 1. Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles.
    Tahara K; Karasawa K; Onodera R; Takeuchi H
    Asian J Pharm Sci; 2017 Jul; 12(4):394-399. PubMed ID: 32104351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification.
    Ying L; Tahara K; Takeuchi H
    Int J Pharm; 2013 Sep; 453(2):329-35. PubMed ID: 23796836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D; Mangal S; Goswami R; Jaganathan KS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytosis-like uptake of surface-modified drug nanocarriers into giant unilamellar vesicles.
    Tahara K; Tadokoro S; Kawashima Y; Hirashima N
    Langmuir; 2012 May; 28(18):7114-8. PubMed ID: 22515197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
    Tahara K; Yamamoto H; Kawashima Y
    Eur J Pharm Biopharm; 2010 Jun; 75(2):218-24. PubMed ID: 20332026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
    Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
    Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
    Pandit J; Sultana Y; Aqil M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
    Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
    Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes.
    Kalam MA; Alshamsan A
    Biomed Pharmacother; 2017 Oct; 94():402-411. PubMed ID: 28772219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery.
    Dandamudi M; McLoughlin P; Behl G; Rani S; Coffey L; Chauhan A; Kent D; Fitzhenry L
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical ocular delivery of nanoparticles with epoetin beta in Wistar Hannover rats.
    Silva B; Gonçalves LM; São Braz B; Delgado E
    Sci Rep; 2023 Jan; 13(1):1559. PubMed ID: 36707615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration.
    Cai H; Wen X; Wen L; Tirelli N; Zhang X; Zhang Y; Su H; Yang F; Chen G
    Int J Nanomedicine; 2014; 9():5591-601. PubMed ID: 25489245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
    Cai H; Liang Z; Huang W; Wen L; Chen G
    Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
    Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.